Aleos

Headquarters
SpainMadrid, Spain
Founded
Founded 2025
Company size
1-10 employees
LinkedIn
LinkedIn
United KingdomUkraineTurkeySwitzerlandSwedenSpainSlovakiaSloveniaSerbiaRomaniaPortugalPolandNorwayNetherlandsMontenegroMoldovaMaltaNorth MacedoniaLuxembourgLithuaniaLatviaKosovoItalyIrelandIcelandHungaryGreeceGermanyFranceFinlandEstoniaDenmarkCzech RepublicCyprusCroatiaBulgariaBosniaBelgiumBelarusAustriaAlbania
Headquartered in Madrid, Spain

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds
1
Reported volume
€150m
Latest public closing
16 Mar 2026

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Spanish private equity firm investing in Iberian lower-mid-market biosciences companies.

Focus: Iberian lower-mid-market biosciences, especially health and wellness, sustainable nutrition, and climate and environment

February 2026: Aleos Fund I held a first close with over €150m raised; the firm expects a larger final close (company site).

Tracked funds

Showing 1 of 1 funds